Global share markets fell over the past week hit by a combination of concerns around coronavirus vaccine efficacy and roll out and delays to extra US stimulus as US retail day traders added to volatility.

Will the continuing run of mostly strong Australian data shift the RBA from dovish to hawkish?

Nothing’s gonna keep the irrepressible Shane Oliver from giving you his views on Trump’s exit, Biden’s new presidency and Covid vaccinations, and how all this will impact our share market!

Share markets down, Aussie dollar on the up, vaccinations kick off and more!

The roll out of vaccines and US stimulus optimism have seen global markets move higher, while the latest coronavirus outbreak in Sydney weighed on Australian shares.

Things seem relatively positive for the Australian share market and the $A.

While Coronavirus cases are still rising in many countries, the good news is that a vaccine is out there and there’s a good chance of reaching herd immunity globally by the end of 2021 or early 2022.

The wind-down to Christmas and the New Year is underway. But there are still a few statistical hurdles to clear before Christmas, including the all-important November labour force report.

The year may be coming to an end but there is no end to the amount of insightful data to assist investors with their investment and budget planning decisions.

Vaccine news keeps getting better and good returns for shares expected.

A quirk of the statistical schedule is that each change of season is ushered in by a barrage of economic data and events. And there will be more than a dozen indicators released over the first week of Summer.

Let’s take a look at the virus, the performance of the share market and whether Donald is saying good-bye yet.